Summary: · Change of name to N4 Pharma Plc (formerly Onzima Ventures Plc) effective · £1.5 million (gross) raised by way of a placing of 21,428,571 New Ordinary Shares at 7p per
Shell Companies ‘Rise in Interest’? in 2016
Closing 2015 the small cap markets took a keen interest in shell companies predominantly listed on AIM, I believe this has been born out of change.
